3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
4
Lymphoid
1
Conditions
Uterine Cervical Neoplasms
1
Lymphoma, Follicular
1
Endometrial Neoplasms
1
Disease
1
Interventions
pembrolizumab
4
Nivolumab
4
Surveys and Questionnaires
3
atezolizumab
2
aflibercept
2
Specimen Handling
2
Methods
2
Magnetic Resonance Spectroscopy
2
Blood Specimen Collection
2
zimberelimab
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
fludarabine
1
erdafitinib
1
entinostat
1
durvalumab
1
defactinib
1
dabrafenib
1
copanlisib
1
ciforadenant
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Diffusion Magnetic Resonance Imaging
×
Lymphoid
×
Clear all
NCT01836484
2020-02-13
MAPPING
Barts & The London NHS Trust
Completed
162 enrolled